Skip to main content

Table 1 Distribution of patients within the different PSA ranges and median values for tPSA, %fPSA and prostate volume for all patients

From: Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity

 

All patients

PCa

BPH

tPSA range (ng/mL)

number

tPSA (ng/mL)

%fPSA (%)

volume (ml)

number

tPSA (ng/mL)

%fPSA (%)

volume (ml)

number

tPSA (ng/mL)

%fPSA (%)

volume (ml)

0–4

47

2.1

19.4

40

2

3.5

17.2

36.5

45

2.1

19.5

40

4.1–10

94

5.6

15.9

44.5

24

5.8

14.3*

33.5*

70

5.6

17.4

50

10.1–20

50

13.6

11

49.1

20

13.5

9.7*

44.5*

30

13.9

13.7

59

>20

8

25.7

9

35.5

3

29.3

6.8*

35*

5

25.6

11

80

all

199

6.2

15.1

45

49

8.3*

10.9*

35*

150

5.3

16.7

47

  1. *significantly different from BPH patients with P < 0.0001